Investor's Business Daily on MSN1h
Novartis Pares Gains As Its Bread-And-Butter Drug Faces Looming Competition
Novartis stock closed flat Friday after the drugmaker beat fourth-quarter expectations, largely on the back of its heart failure drug Entresto.
Health Care Roundup: Market Talk
The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET ...
Becker's Hospital Review52m
Drugmakers increase prices on 800 medications: 5 things to know
Drugmakers have raised the list prices of more than 800 prescription drugs — ranging from blood pressure medications to cancer treatments — by a median of 4% at the start of this year, The Wall Street ...